The startup develops a biotechnology platform that targets activated fibroblast populations to create therapeutics for cancer and inflammatory diseases. By interrupting fibroblast-mediated effects on immune cells, the platform aims to provide effective treatments for rare and life-threatening conditions.
Funding
$45.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IUFounders
Product
Problem
Many cancers and inflammatory diseases are driven by activated fibroblast populations that suppress immune cell activity. Current treatments often fail to address the underlying fibroblast-mediated effects, leading to limited efficacy and potential for disease progression.
Solution
This startup is developing a biotechnology platform that targets and modulates activated fibroblast populations to create novel therapeutics for cancer and inflammatory diseases. By selectively interrupting the fibroblast-mediated suppression of immune cells, the platform aims to restore immune function within the diseased tissue microenvironment. This approach has the potential to provide more effective and targeted treatments for a range of rare and life-threatening conditions. The platform focuses on modulating the interaction between fibroblasts and immune cells, shifting the balance from immune suppression to immune activation and tumor rejection. This modulation is achieved through targeted therapeutic interventions that specifically address the signaling pathways and mechanisms driving fibroblast activation and immune suppression.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions focused on developing innovative therapies for cancer and inflammatory diseases.
Features
- Targeted modulation of activated fibroblast populations within the tumor microenvironment.
- Interruption of fibroblast-mediated suppression of immune cell activity.
- Restoration of immune function within diseased tissues.
- Development of novel therapeutics for cancer and inflammatory diseases.